Download presentation
Presentation is loading. Please wait.
1
Volume 12, Issue 3, Pages 588-595 (March 2015)
Thoracic Spinal Cord Stimulation for Heart Failure as a Restorative Treatment (SCS HEART study): First-in-man experience Hung-Fat Tse, MD, PhD, Stuart Turner, MD, PhD, Prashanthan Sanders, MD, PhD, FHRS, Yuji Okuyama, MD, PhD, Katsuhito Fujiu, MD, PhD, Chi-Wai Cheung, MD, Marc Russo, MD, FHRS, Matthew D.S. Green, MD, Kai-Hang Yiu, MD, Peter Chen, PhD, Chika Shuto, OMD, Elizabeth O.Y. Lau, PhD, Chung-Wah Siu, MD Heart Rhythm Volume 12, Issue 3, Pages (March 2015) DOI: /j.hrthm Copyright © 2015 Heart Rhythm Society Terms and Conditions
2
Figure 1 A: Radiologic image of the 2 octropolar electrodes with 1 targeted at the midline and the other targeted at left of the midline to cover the T1–T3 level. B: Flow diagram of patient recruitment. HF = heart failure; SCS = spinal cord stimulation; VF = ventricular fibrillation; VT = ventricular tachycardia. Heart Rhythm , DOI: ( /j.hrthm ) Copyright © 2015 Heart Rhythm Society Terms and Conditions
3
Figure 2 Changes in the primary efficacy endpoints: New York Heart Association (NYHA), Minnesota Living with Heart Failure Questionnaire (MLHFQ), peak maximum oxygen consumption (VO2max), N-terminal prohormone brain natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF), and left ventricular end-systolic volume (LVESV) after 6 months of spinal cord stimulation. Heart Rhythm , DOI: ( /j.hrthm ) Copyright © 2015 Heart Rhythm Society Terms and Conditions
4
Figure 3 Changes in New York Heart Association class (A), peak maximum oxygen consumption (VO2max) (B), N-terminal prohormone brain natriuretic peptide (NT-proBNP) (C), left ventricular ejection fraction (D), and left ventricular end-systolic volume (E) in spinal cord stimulation (SCS)–treated group and nontreated group at 6 months vs baseline. Data are given as mean ± SD. Heart Rhythm , DOI: ( /j.hrthm ) Copyright © 2015 Heart Rhythm Society Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.